Moreover, oral supplementation of LSM to short bowel syndrome rats recovering from intestinal resection, reduced mucosal and systemic inflammation as shown by reduced concentrations of endotoxin in the serum and lowered pro-inflammatory cytokines (IL-6 and TNF-α) in the intestinal tissue (11). The gene discussed is TNF; the disease is short bowel syndrome.